Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

Name: Medicxi Ventures Management (Jersey) Ltd Q3 2022 13F Filing | 13F Explorer
Creator: Medicxi Ventures Management (Jersey) Ltd
Published: 2022-10-25

Location: St. Helier, Jersey

CIK: 0001715579 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Oct 25, 2022

Total Value: $240M (100.0% shares, 0.0% debt)

Holdings (5)

CNTA CENTESSA PHARMACEUTICALS PLC 33.4%

Value $80.25M Shares 19,963,157 Share Price $4.02 Est. Cost/Share $20.88 Unrealized @ Report Date —

AURA AURA BIOSCIENCES INC 22.9%

Value $55.08M Shares 3,039,892 Share Price $18.12 Est. Cost/Share $17.87 Unrealized @ Report Date +1.4%

PCVX VAXCYTE INC 18.9%

Value $45.3M Shares 1,887,478 Share Price $24.00 Est. Cost/Share $32.16 Unrealized @ Report Date -25.4%

— MERUS N V 13.3%

Value $32.05M Shares 1,600,000 Share Price $20.03 Est. Cost/Share $14.08 Unrealized @ Report Date —

PHAT PHATHOM PHARMACEUTICALS INC 11.5%

Value $27.53M Shares 2,484,274 Share Price $11.08 Est. Cost/Share $22.63 Unrealized @ Report Date -51.0%

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
CNTA	CENTESSA PHARMACEUTICALS PLC	19,963,157	$80.25M	33.4%	$4.02	$20.88	—	SPONSORED ADS	152309100
AURA	AURA BIOSCIENCES INC	3,039,892	$55.08M	22.9%	$18.12	$17.87	+1.4%	COM	05153U107
PCVX	VAXCYTE INC	1,887,478	$45.3M	18.9%	$24.00	$32.16	-25.4%	COM	92243G108
—	MERUS N V	1,600,000	$32.05M	13.3%	$20.03	$14.08	—	COM	N5749R100
PHAT	PHATHOM PHARMACEUTICALS INC	2,484,274	$27.53M	11.5%	$11.08	$22.63	-51.0%	COM	71722W107